Get the Stockscreener App
3.42
2.84%
-0.10
After Hours:
3.42
Qualigen Therapeutics Inc Stock (QLGN) Forecast
The Qualigen Therapeutics Inc (QLGN) stock price forecast for the next 30 days is generally positive, with an average analyst price target of $25.42, representing a +643.40% increase from the current price of $3.42. The highest analyst price target is $25.35, and the lowest is $25.50.
Disclaimer: The information on this page is not intended to be financial advice. It is for general information only and should not be used to make any investment decisions. Please consult with a professional financial advisor before making any investment decisions.
12-Month QLGN Price Target
Average 24.28
(+609.87% Upside)
Is Qualigen Therapeutics Inc (QLGN) A Buy Now?
Oscillators
| Name | Value | Action |
|---|---|---|
| RSI(14) | 43.81 | Neutral |
| STOCH(9,6) | 33.73 | Neutral |
| STOCHRSI(14) | 12.84 | Buy |
| MACD(12,26) | -0.00973 | Sell |
| ADX(14) | 30.48 | Buy |
| William %R | -87.02 | Buy |
| CCI(14) | -152.33 | Sell |
Buy: 3
Sell: 2
Neutral: 2
Summary: Buy
Moving Averages
| Period | Simple | Exponential |
|---|---|---|
| MA10 |
3.6978
Sell
|
3.6766
Sell
|
| MA20 |
3.7525
Sell
|
3.7064
Sell
|
| MA50 |
3.6085
Sell
|
3.6553
Sell
|
| MA100 |
3.4601
Buy
|
3.9173
Sell
|
| MA200 |
4.6929
Sell
|
5.8815
Sell
|
Buy: 1
Sell: 9
Neutral: 0
Summary: Sell
According to our latest analysis, QLGN could be considered a Strong Sell, with 17 technical analysis indicators signaling 4 Buy signals, 11 signaling Sell signals and 2 Neutral signals. This might not be a good time to consider opening new positions on QLGN, as trading bearish markets can be challenging and may result in losses.
- RSI (Relative Strength Index): The RSI(14) value of 43.81 indicates that QLGN is neither overbought nor oversold. It suggests a neutral sentiment in the short term.
- STOCH (Stochastic Oscillator): The STOCH value of 33.73 indicates that QLGN is neither overbought nor oversold. It indicates a balanced market sentiment without any extreme buying or selling pressure.
- STOCHRSI (Stochastic Relative Strength Index): The STOCHRSI value of 12.84 indicates that QLGN is oversold. This suggests that QLGN price is at or near the lowest level relative to its recent price history.
- ADX (Average Directional Index): The ADX value of The ADX value of 30.48 suggests a moderate trend in the market. It indicates that there is more conviction behind the directional movement compared to lower ADX values. You should consider this as a potential opportunity to enter trades in the direction of the trend.
- CCI (Commodity Channel Index): A CCI(14) value of A CCI(14) value of -152.33 indicates that QLGN is oversold. This means that the price has moved significantly lower than its average, indicating a potential buying opportunity.
Long-term QLGN price forecast for 2025, 2030, 2035, 2040, 2045 and 2050
Based on our analysis about Qualigen Therapeutics Inc financial reports and earnings history, Qualigen Therapeutics Inc (QLGN) stock could reach $63.13 by 2030, $70.35 by 2040 and $326.46 by 2050. See the projected annual prices until 2050 of the Qualigen Therapeutics Inc stock below:
- Qualigen Therapeutics Inc (QLGN) is expected to reach an average price of $75.49 in 2035, with a high prediction of $77.05 and a low estimate of $75.58. This indicates an $2,107% rise from the last recorded price of $3.42.
- Qualigen Therapeutics Inc (QLGN) stock is projected to chart a bullish course in 2040, with an average price target of $67.59, representing an $1,876% surge from its current level. The forecast ranges from a conservative $67.59 to a sky-high $70.35.
- Our analysts predict Qualigen Therapeutics Inc (QLGN) to jump 972.96% by 2045, soaring from $36.77 to an average price of $36.70, potentially reaching $40.32. While $36.77 is the low estimate, the potential upside is significant.
- Qualigen Therapeutics Inc (QLGN) stock is expected to climb by 2050, reaching an average of $321.96, a $9,314% jump from its current level. However, a wide range of estimates exists, with high and low targets of $326.46 and $324.46, respectively, highlighting the market's uncertainty.
Qualigen Therapeutics Inc Stock (QLGN) Year by Year Forecast
Qualigen Therapeutics Inc Stock (QLGN) Price Forecast for 2025
Qualigen Therapeutics Inc Stock (QLGN) is expected to reach an average price of $21.45 in 2025, with a high prediction of $26.17 and a low estimate of $16.73. This indicates an +527.12% rise from the last recorded price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| August, 2025 | $26.15 | $25.50 | $25.35 | +664.70% |
| September, 2025 | $25.96 | $26.06 | $25.96 | +659.12% |
| October, 2025 | $24.72 | $23.17 | $26.17 | +622.89% |
| November, 2025 | $24.53 | $24.73 | $24.23 | +617.31% |
| December, 2025 | $25.30 | $24.83 | $25.21 | +639.68% |
Qualigen Therapeutics Inc Stock (QLGN) Price Forecast for 2026
The predicted value for Qualigen Therapeutics Inc (QLGN) in 2026 is set at an average of $22.83. Estimates vary from a peak of $26.00 to a trough of $19.66, indicating an +567.57% surge from the present price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2026 | $26.60 | $25.85 | $26.00 | +677.90% |
| February, 2026 | $25.98 | $26.54 | $25.96 | +659.65% |
| March, 2026 | $25.07 | $24.92 | $24.81 | +633.01% |
| April, 2026 | $24.35 | $24.62 | $24.13 | +611.94% |
| May, 2026 | $22.97 | $23.29 | $23.93 | +571.50% |
| June, 2026 | $22.10 | $22.39 | $22.08 | +546.26% |
| July, 2026 | $22.37 | $22.39 | $22.00 | +554.16% |
| August, 2026 | $21.67 | $21.82 | $21.58 | +533.61% |
| September, 2026 | $21.48 | $21.38 | $21.24 | +528.20% |
| October, 2026 | $20.88 | $20.96 | $20.98 | +510.54% |
| November, 2026 | $20.25 | $20.53 | $20.59 | +492.12% |
| December, 2026 | $19.63 | $19.66 | $19.73 | +473.97% |
Qualigen Therapeutics Inc Stock (QLGN) Price Forecast for 2027
For 2027, Stockscan's Analyst expects the average price target for Qualigen Therapeutics Inc (QLGN) is $13.44, with a high forecast of $19.31 and a low forecast of $7.5707. This indicates an +293.02% increase from the last price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2027 | $18.69 | $18.88 | $19.31 | +446.45% |
| February, 2027 | $17.84 | $17.93 | $18.27 | +421.57% |
| March, 2027 | $16.74 | $16.78 | $17.40 | +389.56% |
| April, 2027 | $15.94 | $15.97 | $16.42 | +365.94% |
| May, 2027 | $14.94 | $14.97 | $15.66 | +336.75% |
| June, 2027 | $13.74 | $13.75 | $14.67 | +301.67% |
| July, 2027 | $12.73 | $12.73 | $13.46 | +272.13% |
| August, 2027 | $11.58 | $11.79 | $12.45 | +238.59% |
| September, 2027 | $10.42 | $10.42 | $11.22 | +204.60% |
| October, 2027 | $9.4462 | $9.4662 | $10.10 | +176.20% |
| November, 2027 | $8.4551 | $8.4951 | $9.1384 | +147.23% |
| December, 2027 | $7.4486 | $7.5707 | $8.1174 | +117.80% |
Qualigen Therapeutics Inc Stock (QLGN) Price Forecast for 2028
In 2028, Qualigen Therapeutics Inc (QLGN) is projected to reach an average price of $32.62, with a high projection of $64.99 and a low estimate of $0.2548. This indicates an +853.88% rise from the last price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2028 | $6.5577 | $6.5577 | $7.1796 | +91.75% |
| February, 2028 | $5.6663 | $5.6743 | $6.2049 | +65.68% |
| March, 2028 | $4.5037 | $4.5135 | $5.3896 | +31.69% |
| April, 2028 | $3.5229 | $3.564 | $4.2377 | +3.01% |
| May, 2028 | $2.3707 | $2.3827 | $3.1927 | -30.68% |
| June, 2028 | $1.3894 | $1.4246 | $2.0979 | -59.37% |
| July, 2028 | $0.4938 | $0.5031 | $1.1369 | -85.56% |
| August, 2028 | $59.81 | $0.2548 | $58.01 | +1,649% |
| September, 2028 | $59.93 | $61.02 | $62.33 | +1,652% |
| October, 2028 | $54.45 | $57.55 | $56.34 | +1,492% |
| November, 2028 | $68.27 | $58.45 | $63.97 | +1,896% |
| December, 2028 | $65.09 | $67.09 | $64.99 | +1,803% |
Qualigen Therapeutics Inc Stock (QLGN) Price Forecast for 2029
The 2029 price forecast for Qualigen Therapeutics Inc Stock (QLGN) is $63.08 on average, with a high prediction of $69.82 and a low estimate of $56.34. This represents an +1,744% increase from the previous price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2029 | $65.51 | $66.40 | $66.21 | +1,816% |
| February, 2029 | $56.33 | $64.23 | $61.72 | +1,547% |
| March, 2029 | $65.45 | $56.34 | $58.75 | +1,814% |
| April, 2029 | $65.27 | $63.36 | $63.87 | +1,808% |
| May, 2029 | $68.29 | $65.64 | $69.51 | +1,897% |
| June, 2029 | $68.71 | $70.31 | $69.82 | +1,909% |
| July, 2029 | $64.22 | $66.32 | $66.51 | +1,778% |
| August, 2029 | $65.75 | $65.64 | $64.44 | +1,822% |
| September, 2029 | $69.57 | $64.22 | $64.85 | +1,934% |
| October, 2029 | $63.69 | $65.08 | $66.37 | +1,762% |
| November, 2029 | $64.61 | $64.50 | $63.81 | +1,789% |
| December, 2029 | $63.42 | $63.52 | $63.81 | +1,754% |
Qualigen Therapeutics Inc Stock (QLGN) Price Forecast for 2030
Qualigen Therapeutics Inc Stock (QLGN) is expected to reach an average price of $54.54 in 2030, with a high forecast of $63.13 and a low forecast of $45.96. This signifies an +1,495% surge from the last price of $3.42.
| Month | Average | Low | High | Change from today's price |
|---|---|---|---|---|
| January, 2030 | $60.95 | $59.64 | $63.13 | +1,682% |
| February, 2030 | $59.76 | $59.96 | $59.95 | +1,647% |
| March, 2030 | $60.38 | $59.56 | $58.98 | +1,666% |
| April, 2030 | $59.47 | $59.47 | $59.21 | +1,639% |
| May, 2030 | $57.99 | $58.62 | $59.00 | +1,596% |
| June, 2030 | $56.09 | $56.19 | $56.58 | +1,540% |
| July, 2030 | $54.13 | $54.76 | $54.16 | +1,483% |
| August, 2030 | $51.76 | $52.08 | $53.47 | +1,413% |
| September, 2030 | $49.90 | $50.19 | $50.62 | +1,359% |
| October, 2030 | $48.93 | $49.02 | $49.50 | +1,331% |
| November, 2030 | $47.24 | $47.54 | $47.83 | +1,281% |
| December, 2030 | $45.96 | $45.96 | $46.56 | +1,244% |
2.10%
1.57%
Open in Yahoo
|
Open in Google
|
Open in Finviz
|
Open in MarketWatch
|
Open in EDGAR
|
Open in Reuters
Cap:
|
Volume (24h):